WHO ICTRP trial
COMBINATORY IMMUNOTHERAPY-2 (COM-IT-2) A phase 2 randomised open two-arm study…
CTIS2023-510089-28-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-510089-28-00 |
|---|---|
| Public title | COMBINATORY IMMUNOTHERAPY-2 (COM-IT-2) A phase 2 randomised open two-arm study to assess the tolerability and efficacy of immunotherapy combined with extensive radiotherapyfor the treatment of stage IV non-small cell lung cancer |
| Scientific title | Combinatory ImmunoTherapy-2 (Com-IT-2) A phase 2 randomised open two-arm study to assess the tolerability and efficacy of immunotherapy combined with extensive radiotherapy for the treatment of stage IV non-small cell lung cancer |
| Primary sponsor | Oslo University Hospital HF |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Norway |
| Conditions | Non-small cell lung cancer (Stage IV);Therapeutic area: Diseases [C] - Pathological Conditions, Signs and Symptoms [C23] |
| Interventions | Product Name: OPDIVO 10 mg/mL concentrate for solution for infusion., Product Code:PRD6183485, Pharmaceutical Form: SOLUTION FOR INFUSION, Other descriptive name: , Strength: , Product Name: KEYTRUDA 25 mg/mL concentrate for solution for… |
| Registration date | Aug 4, 2024 |
| Target size | 30 |
| Secondary IDs | 2021-003266-13 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: